Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Feuvret

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 12, 2014
Randomized phase II trial of irinotecan and bevacizumab as neo-adjuvant and adjuvant to temozolomide-based chemoradiation compared with temozolomide-chemoradiation for unresectable glioblastoma: final results of the TEMAVIR study from ANOCEF†B Chauffert, L Feuvret, F Bonnetain, et al.
Bulletin Du Cancer|September 8, 1999
[First treatment for brain metastases by stereotactic radiosurgery]L Feuvret, I Germain, P Cornu, et al.
Journal of Neuro-Oncology|May 13, 2016
Prognostic and therapeutic factors of gliosarcoma from a multi-institutional seriesJ Castelli, L Feuvret, Q C Haoming, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 28, 1998
[Importance of radiotherapy in stereotactic conditions (radiosurgery) in brain metastasis: experience and results of the Hôpital Pitié-Salpêtrière Group]L Feuvret, I Germain, P Cornu, et al.
Neuro-Chirurgie|May 27, 2014
[Chordoma]B George, D Bresson, S Bouazza, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 12, 2014
Randomized phase II trial of irinotecan and bevacizumab as neo-adjuvant and adjuvant to temozolomide-based chemoradiation compared with temozolomide-chemoradiation for unresectable glioblastoma: final results of the TEMAVIR study from ANOCEF†B Chauffert, L Feuvret, F Bonnetain, et al.
Bulletin Du Cancer|September 8, 1999
[First treatment for brain metastases by stereotactic radiosurgery]L Feuvret, I Germain, P Cornu, et al.
Journal of Neuro-Oncology|May 13, 2016
Prognostic and therapeutic factors of gliosarcoma from a multi-institutional seriesJ Castelli, L Feuvret, Q C Haoming, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 28, 1998
[Importance of radiotherapy in stereotactic conditions (radiosurgery) in brain metastasis: experience and results of the Hôpital Pitié-Salpêtrière Group]L Feuvret, I Germain, P Cornu, et al.
Neuro-Chirurgie|May 27, 2014
[Chordoma]B George, D Bresson, S Bouazza, et al.
Pageof 6